secwatch.observer — SEC 8-K summary
======================================

Issuer:     IN8BIO, INC. (INAB)
CIK:        0001740279
Form:       8-K
Filed at:   2026-02-27T23:59:59+00:00
Accession:  0001193125-26-082539
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

IN8bio director Alan Roemer resigns; Jeremy Graff appointed Interim Chair
-------------------------------------------------------------------------

- Alan S. Roemer resigned as director and from Audit and Compensation Committees, effective Feb 28, 2026.
- Resignation not due to any disagreement with company, management, or board on operations, policies, or practices.
- Board appointed Jeremy Graff, an independent director, as Interim Chair of the Board effective Feb 28, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1740279/000119312526082539/0001193125-26-082539-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1740279/000119312526082539/d915471d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-082539

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer